$FDMT Cashflow Statement | Understand Stock

$FDMT

$11.03 +$0.23 (2.13%) Close

$FDMT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation expense
Vesting of common stock warrants in return for services
Change in fair value of derivative liability
Depreciation and amortization
Amortization of right-of-use assets
Net accretion of discount on marketable securities
Changes in operating assets and liabilities
Accounts receivable
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued and other liabilities
Deferred revenue
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchase of marketable securities
Maturities of marketable securities
Acquisition of property and equipment
Net cash used in investing activities
Cash flows from financing activities
Issuance of redeemable convertible preferred stock, net of issuance costs
Issuance of common stock upon exercise of stock options and vesting of RSUs
Issuance of common stock under the offering program, net of issuance costs
Public Offering
ATM Offering Program
Underwritten offering
Employee Stock Purchase Plan
Total issuance of common stock under the offering program, net of issuance costs

Issuance of common stock upon exercise of stock options and warrants
Issuance of common stock through 2020 ESPP
Issuance of common stock - 2020 ESPP
Issuance of common stock under stock purchase agreement
Payment of offering costs
Net cash provided by financing activities

Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosures of noncash investing and financing information
Conversion of redeemable convertible preferred stock into common stock
Unpaid stock issuance costs in accrued and other liabilities
Purchases of property and equipment in accounts payable and accrued and other liabilities
Receivable for common stock issued upon exercise of stock options
Right-of-use assets obtained in exchange for lease obligations
Deferred ATM costs reclassification
Unpaid offering costs
Issuance of common stock warrant to settle liability

Comments